| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute coronary syndromes: Targeting the vulnerable atherosclerotic plaque – new approaches for stabilization and regression of the plaque
|
Pillarisetti, Sivaram
|
|
2008
|
|
1 |
p. 37-43
7 p.
|
artikel
|
| 2 |
Adenosine A2A-receptor antagonists: beyond dopaminergic therapies for Parkinson's disease
|
Kase, Hiroshi
|
|
2004
|
|
1 |
p. 51-57
7 p.
|
artikel
|
| 3 |
Administration of erythropoietin and its derivatives in renal disease: Advantages, mechanisms and concerns
|
Gobe, Glenda C.
|
|
2007
|
|
1 |
p. 79-84
6 p.
|
artikel
|
| 4 |
Adoptive T lymphocyte therapy to fight cytomegalovirus infection in immunodeficient hosts
|
Grigoleit, Ulrich
|
|
2006
|
|
1 |
p. 63-68
6 p.
|
artikel
|
| 5 |
Allogeneic hematopoietic stem cell transplantation for malignant disease: How to prevent graft-versus-host disease without jeopardizing the graft-versus-tumor effect?
|
Lewalle, Philippe
|
|
2006
|
|
1 |
p. 25-30
6 p.
|
artikel
|
| 6 |
Allosteric modulators of class-C G-protein-coupled receptors open new possibilities for therapeutic application
|
Goudet, Cyril
|
|
2004
|
|
1 |
p. 125-133
9 p.
|
artikel
|
| 7 |
Alpha adrenoreceptor antagonists – have we reached the optimum balance of safety/efficacy?
|
Jelski, Joseph
|
|
2012
|
|
1 |
p. e27-e33
nvt p.
|
artikel
|
| 8 |
Anti-inflammatory modulators in stroke
|
O’Neill, Michael J.
|
|
2004
|
|
1 |
p. 59-67
9 p.
|
artikel
|
| 9 |
Antimicrobial peptides in skin disease
|
Schröder, Jens-M.
|
|
2006
|
|
1 |
p. 93-100
8 p.
|
artikel
|
| 10 |
Antimuscarinic therapy – what is new?
|
Gomelsky, Alex
|
|
2012
|
|
1 |
p. e21-e25
nvt p.
|
artikel
|
| 11 |
Autoimmune disorders: toward more efficient and safer therapies
|
Goldman, Michel
|
|
2009
|
|
1 |
p. 1-3
3 p.
|
artikel
|
| 12 |
Biomarkers: Strategies to predict outcome of rheumatoid arthritis
|
Saleem, Benazir
|
|
2006
|
|
1 |
p. 11-16
6 p.
|
artikel
|
| 13 |
Botulinum toxin therapy for the management of lower urinary tract symptoms – has this come of age?
|
Mangera, Altaf
|
|
2012
|
|
1 |
p. e35-e39
nvt p.
|
artikel
|
| 14 |
Can you reduce your AGE?
|
Coughlan, Melinda T.
|
|
2007
|
|
1 |
p. 85-92
8 p.
|
artikel
|
| 15 |
Cardiovascular consequences of obesity
|
Poirier, Paul
|
|
2008
|
|
1 |
p. 45-51
7 p.
|
artikel
|
| 16 |
Cardiovascular consequences of obesity and targets for treatment
|
Mittendorfer, Bettina
|
|
2008
|
|
1 |
p. 53-61
9 p.
|
artikel
|
| 17 |
Cardiovascular diseases
|
Macphee, Colin H.
|
|
2008
|
|
1 |
p. 1-3
3 p.
|
artikel
|
| 18 |
CD3-specific antibodies to restore tolerance in autoimmune diabetes
|
You, Sylvaine
|
|
2009
|
|
1 |
p. 33-38
6 p.
|
artikel
|
| 19 |
Cell-based therapies for Parkinson's disease
|
Foster, George A.
|
|
2004
|
|
1 |
p. 43-49
7 p.
|
artikel
|
| 20 |
Combination therapy in the management of LUTS – is this the future?
|
Chughtai, Bilal
|
|
2012
|
|
1 |
p. e15-e19
nvt p.
|
artikel
|
| 21 |
Complement therapy in dry age-related macular degeneration
|
Punjabi, Omar S.
|
|
2013
|
|
1 |
p. e5-e10
nvt p.
|
artikel
|
| 22 |
Contents
|
|
|
2009
|
|
1 |
p. i-
1 p.
|
artikel
|
| 23 |
Contents
|
|
|
2006
|
|
1 |
p. i-
1 p.
|
artikel
|
| 24 |
Contents
|
|
|
2004
|
|
1 |
p. i-
1 p.
|
artikel
|
| 25 |
Contents
|
|
|
2007
|
|
1 |
p. i-
1 p.
|
artikel
|
| 26 |
Contents
|
|
|
2005
|
|
1 |
p. i-
1 p.
|
artikel
|
| 27 |
Contents
|
|
|
2013
|
|
1 |
p. i-
1 p.
|
artikel
|
| 28 |
Contents
|
|
|
2008
|
|
1 |
p. i-
1 p.
|
artikel
|
| 29 |
Contents
|
|
|
2012
|
|
1 |
p. i-
1 p.
|
artikel
|
| 30 |
Contrasting the neuroprotective and gliotoxic effects of PPARγ agonists
|
Feinstein, Douglas L.
|
|
2004
|
|
1 |
p. 29-34
6 p.
|
artikel
|
| 31 |
Co-stimulatory molecules as therapeutic targets in allergic airways disease
|
Suchard, Suzanne J.
|
|
2007
|
|
1 |
p. 39-47
9 p.
|
artikel
|
| 32 |
Cyclooxygenase products and atherosclerosis
|
Linton, MacRae F.
|
|
2008
|
|
1 |
p. 25-36
12 p.
|
artikel
|
| 33 |
Drug development for LUTS – The challenge for industry
|
Perabo, Frank G.E.
|
|
2012
|
|
1 |
p. e5-e14
nvt p.
|
artikel
|
| 34 |
Drug treatment of premature ejaculation: Pharmacodynamic and pharmacokinetic paradigms
|
Waldinger, Marcel D.
|
|
2005
|
|
1 |
p. 37-40
4 p.
|
artikel
|
| 35 |
Editorial
|
|
|
2006
|
|
1 |
p. 1-3
3 p.
|
artikel
|
| 36 |
Editorial
|
|
|
2005
|
|
1 |
p. iii-v
nvt p.
|
artikel
|
| 37 |
Endothelial progenitor cells in the treatment of acute ischemic renal failure
|
Patschan, D.
|
|
2007
|
|
1 |
p. 65-70
6 p.
|
artikel
|
| 38 |
Gene therapeutic strategies for blistering skin diseases
|
Titeux, Matthias
|
|
2006
|
|
1 |
p. 87-92
6 p.
|
artikel
|
| 39 |
Harnessing the regulatory feedback to T cells to enhance antitumor immune responses
|
Qiao, Yu
|
|
2006
|
|
1 |
p. 31-34
4 p.
|
artikel
|
| 40 |
Hypereosinophilic syndromes: A novel therapeutic indication for tyrosine kinase inhibitors and IL-5 antagonists
|
Roufosse, Florence
|
|
2006
|
|
1 |
p. 55-61
7 p.
|
artikel
|
| 41 |
Imaging in DRY AMD
|
Normando, Eduardo M.
|
|
2013
|
|
1 |
p. e35-e41
nvt p.
|
artikel
|
| 42 |
Improving the therapeutic window in the treatment of pain with nicotinic ligands
|
Rueter, Lynne E.
|
|
2004
|
|
1 |
p. 89-96
8 p.
|
artikel
|
| 43 |
Indications of Rituximab in autoimmune diseases
|
Sanz, Iñaki
|
|
2009
|
|
1 |
p. 13-19
7 p.
|
artikel
|
| 44 |
Inhibitors of beta-amyloid aggregation: still an issue of structure and function?
|
Talaga, Patrice
|
|
2004
|
|
1 |
p. 7-12
6 p.
|
artikel
|
| 45 |
Intravenous polyclonal immunoglobulin in autoimmune diseases: clinical indications and mechanisms of action
|
Maddur, Mohan S.
|
|
2009
|
|
1 |
p. 5-11
7 p.
|
artikel
|
| 46 |
Male erectile dysfunction: Chemical pharmacology of penile erection
|
Argiolas, Antonio
|
|
2005
|
|
1 |
p. 31-36
6 p.
|
artikel
|
| 47 |
Medications for the treatment of cocaine addiction: Emerging candidates
|
Herman, Barbara H.
|
|
2005
|
|
1 |
p. 87-92
6 p.
|
artikel
|
| 48 |
Monoamine transporters as continuing targets for drug discovery in depression
|
Klint, Thorsten
|
|
2004
|
|
1 |
p. 111-116
6 p.
|
artikel
|
| 49 |
Natalizumab update: a story of benefit and risk
|
Barten, Laurie J.
|
|
2009
|
|
1 |
p. 21-31
11 p.
|
artikel
|
| 50 |
New approaches to prevent transplant rejection: Co-stimulation blockers anti-CD40L and CTLA4Ig
|
Pree, Ines
|
|
2006
|
|
1 |
p. 41-47
7 p.
|
artikel
|
| 51 |
New aspects of perioperative fluid therapy
|
Burdett, Edward
|
|
2005
|
|
1 |
p. 53-58
6 p.
|
artikel
|
| 52 |
New symptomatic strategies in Alzheimer's disease
|
Johnson, Christopher N.
|
|
2004
|
|
1 |
p. 13-19
7 p.
|
artikel
|
| 53 |
New treatments for cocaine abuse
|
Dackis, Charles A.
|
|
2005
|
|
1 |
p. 79-86
8 p.
|
artikel
|
| 54 |
Nitric oxide-based therapy for erectile disorders
|
Burnett, Arthur L.
|
|
2005
|
|
1 |
p. 25-30
6 p.
|
artikel
|
| 55 |
Novel muscarinic antagonists to treat incontinence and/or overactive bladder
|
Michel, Martin C.
|
|
2005
|
|
1 |
p. 1-6
6 p.
|
artikel
|
| 56 |
Novel strategies for nephroprotection using hypoxia-inducible gene expression
|
Warnecke, Christina
|
|
2007
|
|
1 |
p. 71-77
7 p.
|
artikel
|
| 57 |
Osteoporosis – an immune mediated disease?
|
De Martinis, Massimo
|
|
2007
|
|
1 |
p. 3-9
7 p.
|
artikel
|
| 58 |
Overactive bladder: Targeting prostaglandins in sensory pathways
|
Wibberley, Alexandra
|
|
2005
|
|
1 |
p. 7-13
7 p.
|
artikel
|
| 59 |
Overactive urinary bladder: Targeting sensory pathways
|
Lecci, Alessandro
|
|
2005
|
|
1 |
p. 15-23
9 p.
|
artikel
|
| 60 |
Oxidative mechanisms and atherothrombotic cardiovascular disease
|
Leopold, Jane A.
|
|
2008
|
|
1 |
p. 5-13
9 p.
|
artikel
|
| 61 |
Paediatric anaesthesia – New drug developments
|
Visram, Anil
|
|
2005
|
|
1 |
p. 59-64
6 p.
|
artikel
|
| 62 |
Peptide-based therapy for autoimmune diseases
|
Wraith, David C.
|
|
2006
|
|
1 |
p. 35-40
6 p.
|
artikel
|
| 63 |
Pharmaceutical issues in the development of a polypill for the treatment of cardiovascular diseases
|
Kumar, Vijay
|
|
2008
|
|
1 |
p. 63-71
9 p.
|
artikel
|
| 64 |
Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment
|
Petrukhin, Konstantin
|
|
2013
|
|
1 |
p. e11-e20
nvt p.
|
artikel
|
| 65 |
Pharmacology and prospective therapeutic usefulness of negative allosteric modulators of AMPA receptors
|
Szénási, Gábor
|
|
2004
|
|
1 |
p. 69-76
8 p.
|
artikel
|
| 66 |
Pharmacotherapy of alcohol dependence: Targeting a complex disorder
|
Kenna, George A.
|
|
2005
|
|
1 |
p. 71-78
8 p.
|
artikel
|
| 67 |
Phosphoantigens and aminobisphosphonates: New leads targeting γδ T lymphocytes for cancer immunotherapy
|
Belmant, Christian
|
|
2006
|
|
1 |
p. 17-23
7 p.
|
artikel
|
| 68 |
p38 MAP kinase inhibitors: A future therapy for inflammatory diseases
|
Mayer, Ruth J.
|
|
2006
|
|
1 |
p. 49-54
6 p.
|
artikel
|
| 69 |
Premature ejaculation – Dopaminergic control of ejaculation
|
Andersen, Monica Levy
|
|
2005
|
|
1 |
p. 41-46
6 p.
|
artikel
|
| 70 |
Premature vascular senescence in metabolic syndrome: Could it be prevented and reversed by a selenorganic antioxidant and peroxynitrite scavenger ebselen?
|
Chen, Jun
|
|
2007
|
|
1 |
p. 93-99
7 p.
|
artikel
|
| 71 |
Preterm labour: Novel treatments
|
Gullam, Joanna E
|
|
2005
|
|
1 |
p. 47-52
6 p.
|
artikel
|
| 72 |
Recent advances in dry AMD therapeutic development
|
Thut, Catherine J.
|
|
2013
|
|
1 |
p. e1-e3
nvt p.
|
artikel
|
| 73 |
Recent advances in therapeutic strategies for SLE
|
Stichweh, Dorothee
|
|
2006
|
|
1 |
p. 5-10
6 p.
|
artikel
|
| 74 |
Renal diseases
|
Goligorsky, Michael S.
|
|
2007
|
|
1 |
p. 63-64
2 p.
|
artikel
|
| 75 |
Retinal neuroprotection in dry age-related macular degeneration
|
Chinskey, Nicholas D.
|
|
2013
|
|
1 |
p. e21-e24
nvt p.
|
artikel
|
| 76 |
Role of cytokine therapy in the treatment of psoriasis
|
Zheng, Yan
|
|
2007
|
|
1 |
p. 25-31
7 p.
|
artikel
|
| 77 |
Role of IL-1 and potential therapies in multiple sclerosis
|
Warabi, Yoko
|
|
2007
|
|
1 |
p. 19-24
6 p.
|
artikel
|
| 78 |
Role of purinoceptors in immune-mediated disease (therapies targeting the P2X7 receptor)
|
Tsukimoto, Mitsutoshi
|
|
2007
|
|
1 |
p. 33-37
5 p.
|
artikel
|
| 79 |
γ-Secretase inhibitors: still in the running as Alzheimer’s therapeutics
|
Marjaux, Els
|
|
2004
|
|
1 |
p. 1-6
6 p.
|
artikel
|
| 80 |
Selective GABAA circuits for novel CNS drugs
|
Möhler, H.
|
|
2004
|
|
1 |
p. 117-123
7 p.
|
artikel
|
| 81 |
Serotonergic agents and Parkinson's disease
|
Blackburn, Thomas P.
|
|
2004
|
|
1 |
p. 35-41
7 p.
|
artikel
|
| 82 |
Stem cell therapies in cardiovascular disease
|
Partovian, Chohreh
|
|
2008
|
|
1 |
p. 73-78
6 p.
|
artikel
|
| 83 |
Strategies for developing Nogo antagonists
|
Prinjha, Rab K.
|
|
2004
|
|
1 |
p. 21-27
7 p.
|
artikel
|
| 84 |
Strategies for neuroprotection in the newborn
|
Gressens, Pierre
|
|
2004
|
|
1 |
p. 77-82
6 p.
|
artikel
|
| 85 |
Superhaptens and their potential role in contact dermatitis
|
Günther, Stefan
|
|
2007
|
|
1 |
p. 11-17
7 p.
|
artikel
|
| 86 |
Targeting glia to control clinical pain: an idea whose time has come
|
Watkins, Linda R.
|
|
2004
|
|
1 |
p. 83-88
6 p.
|
artikel
|
| 87 |
Targeting immunological disorders
|
Braddock, Martin
|
|
2007
|
|
1 |
p. 1-2
2 p.
|
artikel
|
| 88 |
Targeting innate immunity for CV benefit
|
Moore, Kathryn J.
|
|
2008
|
|
1 |
p. 15-23
9 p.
|
artikel
|
| 89 |
Targeting interferons in multiple sclerosis
|
Nakatsuji, Yuji
|
|
2007
|
|
1 |
p. 49-55
7 p.
|
artikel
|
| 90 |
The development of novel dermal matrices for cutaneous wound repair
|
Anthony, Edwin T
|
|
2006
|
|
1 |
p. 81-86
6 p.
|
artikel
|
| 91 |
The promise of stem cells for age-related macular degeneration and other retinal degenerative diseases
|
Zarbin, Marco
|
|
2013
|
|
1 |
p. e25-e33
nvt p.
|
artikel
|
| 92 |
Therapeutics for depression and anxiety disorders
|
Holsboer, Florian
|
|
2004
|
|
1 |
p. 105-109
5 p.
|
artikel
|
| 93 |
Therapeutic strategies for treating hair loss
|
Paus, Ralf
|
|
2006
|
|
1 |
p. 101-110
10 p.
|
artikel
|
| 94 |
Therapeutic vaccines for autoimmune diseases
|
Pannemans, Kim
|
|
2009
|
|
1 |
p. 39-44
6 p.
|
artikel
|
| 95 |
Therapeutic vaccines for substance dependence
|
Haney, Margaret
|
|
2005
|
|
1 |
p. 65-69
5 p.
|
artikel
|
| 96 |
The role of Toll: How therapies targeting Toll-like receptors treat skin diseases
|
McInturff, Jamie E.
|
|
2006
|
|
1 |
p. 75-80
6 p.
|
artikel
|
| 97 |
The therapeutic potential of TRPV1 (VR1) antagonists: clinical answers await
|
Rami, Harshad K.
|
|
2004
|
|
1 |
p. 97-104
8 p.
|
artikel
|
| 98 |
Treatment for uterine fibroids: Searching for effective drug therapies
|
Taylor, Darlene K.
|
|
2012
|
|
1 |
p. e41-e49
nvt p.
|
artikel
|
| 99 |
Treatment of autoimmune diseases: A systems biology approach
|
Forero, Iván Martínez
|
|
2007
|
|
1 |
p. 57-62
6 p.
|
artikel
|
| 100 |
Urology
|
Chapple, Christopher
|
|
2012
|
|
1 |
p. e1-e3
nvt p.
|
artikel
|
| 101 |
Visual function endpoints to enable dry AMD clinical trials
|
Lesmes, Luis Andres
|
|
2013
|
|
1 |
p. e43-e50
nvt p.
|
artikel
|
| 102 |
Xenotransplantation: How close are we from clinical application?
|
Cozzi, Emanuele
|
|
2006
|
|
1 |
p. 69-74
6 p.
|
artikel
|
Tijdschrift beschrijving